...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo
【24h】

Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo

机译:形成G-Quadreplex结构的寡核苷酸 - 脂质缀合物是有效的和Pangenotypic丙型肝炎病毒进入抑制剂,体外和离体

获取原文
获取原文并翻译 | 示例
           

摘要

A hepatitis C virus (HCV) epidemic affecting HIV-infected men who have sex with men (MSM) is expanding worldwide. In spite of the improved cure rates obtained with the new direct-acting antiviral drug (DAA) combinations, the high rate of reinfection within this population calls urgently for novel preventive interventions. In this study, we determined in cell culture and ex vivo experiments with human colorectal tissue that lipoquads, G-quadruplex DNA structures fused to cholesterol, are efficient HCV pangenotypic entry and cell-to-cell transmission inhibitors. Thus, lipoquads may be promising candidates for the development of rectally applied gels to prevent HCV transmission.
机译:影响与男性(MSM)发生性关系的艾滋病毒感染者(MSM)的丙型肝炎病毒(HCV)疫情正在全球范围内扩大。 尽管采用新的直接抗病毒药物(DAA)组合获得了改善的固化率,但这种人口内的高速率急需用于新的预防性干预措施。 在这项研究中,我们在细胞培养和离体实验中确定了人结直肠组织,脂肪标题,G-QuadrepleDNA结构融合给胆固醇,是有效的HCV Pangentypic进入和细胞对细胞透射抑制剂。 因此,Lipoquads可能是用于开发直肠施加的凝胶的候选者,以防止HCV变速器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号